Donglin Hao
Impact in
- Pharmacology top 10%
- Pharmacological Effects of Natural Compounds
Papers in
-
- Systemic Lupus Erythematosus Research 4
-
- Immune Cell Function and Interaction 2
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 1
- Co-authors
- Q. P. Hu (4 shared papers)Liangliang Zhang (2 shared papers)Tingting Huang (2 shared papers)Li‐Fang Zhang (1 shared paper)Jianguo Xu (2 shared papers)Jin Zhang (1 shared paper)Lin Zhao (1 shared paper)Dong Shen (1 shared paper)
- Journals
- Food Control (1 paper)Scientific Reports (1 paper)RSC Advances (1 paper)Pharmaceutical Biology (1 paper)Biomedicine & Pharmacotherapy (1 paper)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Donglin Hao
20 papers receiving 443 citations
Peers
Comparison fields: 5 of 89
- Pharmacology 66
- Complementary and alternative medicine 42
- Food Science 81
- Nephrology 29
- Biological Psychiatry 10
Countries citing papers authored by Donglin Hao
This map shows the geographic impact of Donglin Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donglin Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donglin Hao more than expected).
Fields of papers citing papers by Donglin Hao
This network shows the impact of papers produced by Donglin Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donglin Hao. The network helps show where Donglin Hao may publish in the future.
Co-authors
The 25 scholars most cited alongside Donglin Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 82 | |
| 2 | 2017 | 81 | |
| 3 | 2017 | 70 | |
| 4 | 2017 | 61 | |
| 5 | 2015 | 32 | |
| 6 | 2020 | 20 | |
| 7 | 2015 | 19 | |
| 8 | 2018 | 19 | |
| 9 | 2024 | 15 | |
| 10 | 2023 | 14 | |
| 11 | 2020 | 14 | |
| 12 | 2021 | 6 | |
| 13 | 2014 | 6 | |
| 14 | 2021 | 3 | |
| 15 | [Investigation of the risk of hepatitis B virus reactivation in arthritis patients undergoing anti-tumour necrosis factor alpha therapy]. | 2015 | 2 |
| 16 | [The re-evaluation of 140 patients diagnosed as ankylosing spondylitis and nonradiographic axial spondyloarthritis]. | 2013 | 2 |
| 17 | 2023 | 1 | |
| 18 | 2024 | 1 | |
| 19 | [Prospective study of efficacy and safety of hydroxychloroquine in pregnant patients with systemic lupus erythematosus]. | 2014 | 1 |
| 20 | Profiles of Antibacterial Activities of Consecutive Extracts from Naked Oat against Several Food-Related Bacteria | 2014 | 1 |
About Donglin Hao
Donglin Hao is a scholar working on Rheumatology, Immunology, Food Science, Plant Science and Molecular Biology, having authored 20 papers that have together received 450 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (4 papers), Essential Oils and Antimicrobial Activity (3 papers), Bone and Joint Diseases (3 papers), Botany, Ecology, and Taxonomy Studies (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Immune Cell Function and Interaction (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper) and Protein Tyrosine Phosphatases (1 paper). The work is most often cited by research in Pharmacology (66 citations), Complementary and alternative medicine (42 citations), Food Science (81 citations), Nephrology (29 citations) and Biological Psychiatry (10 citations). Donglin Hao has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Q. P. Hu, Liangliang Zhang, Tingting Huang, Li‐Fang Zhang, Jianguo Xu, Jin Zhang, Lin Zhao, Dong Shen, Yiting Zhang and Wenya Xu. Their work appears in journals such as Food Control, Scientific Reports, RSC Advances, Pharmaceutical Biology and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.